Judy Wright
Special to The Citizen
Hopefully everyone recognizes that old medications, whether they are prescription or over-the-counter, should not be flushed down the toilet. The good news is April 24, 2021, is the 19th Drug Enforcement Agency National Prescription Drug Take Back Day. The DEA is an agency of the U.S. Department of Justice.
There has been concern about pharmaceuticals and personal care products (PPCPs) being detected in drinking water for several decades. In 2010, studies found discarded medications in the drinking water source for over 50 million Americans. Since then, the Environmental Protection Agency and U.S. Geological Survey have continued to study PPCPs.
The Social Order
In July 2015, President Obama paid a press-saturated visit to a federal penitentiary in Oklahoma. The cell blocks that Obama toured had been evacuated in anticipation of his arrival, but after talking to six carefully prescreened inmates, he drew some conclusions about the path to prison. “These are young people who made mistakes that aren’t that different than the mistakes I made and the mistakes that a lot of you guys made,” the president told the waiting reporters.
The
New York Times seconded this observation in its front-page coverage of Obama’s prison excursion. There is but a “fine line between president and prisoner,” the paper noted. Anyone who “smoked marijuana and tried cocaine,” as the president had as a young man, could end up in the El Reno Federal Correctional Institution, according to the
Country: Australia
Incredibly energetic, creative, strategic communications / public relations practitioner specializes in campaign development, media relations, training, group facilitation, social media, health promotions, public outreach, and public awareness campaigns. Expertise in developing & designing award-winning collateral materials, web sites and cause marketing campaigns. Able to secure earned media and social media for clients. In the process of developing Communication Checklist to help organisations better reach the African American, Latino, LGBTQ, Transgender and Elderly communities. Coming soon!
While stationed in Washington, DC, Wagner worked as a Media Policy Analyst with the Office of National Drug Control Policy, an Executive Office of the White House managing a national youth anti-drug media campaign. He managed all aspects of social media, marketing, budgeting, public policy, advertising, training, technical writing, and instructional design. He also provided
bmwagner
Country: Australia
Incredibly energetic, creative, strategic communications / public relations practitioner specializes in campaign development, media relations, training, group facilitation, social media, health promotions, public outreach, and public awareness campaigns. Expertise in developing & designing award-winning collateral materials, web sites and cause marketing campaigns. Able to secure earned media and social media for clients. In the process of developing Communication Checklist to help organisations better reach the African American, Latino, LGBTQ, Transgender and Elderly communities. Coming soon!
While stationed in Washington, DC, Wagner worked as a Media Policy Analyst with the Office of National Drug Control Policy, an Executive Office of the White House managing a national youth anti-drug media campaign. He managed all aspects of social media, marketing, budgeting, public policy, advertising, training, technical writing, and instructional design. He als
Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, President Biden signed a bill extending a moratorium on Medicare sequestration through the end of 2021. Read more about the law and other news below.
I. Regulations, Notices & Guidance
On April 15, 2021, the Food and Drug Administration (FDA) issued guidance entitled,
Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency. FDA is issuing this guidance to describe how the agency will request and conduct voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, or held; facilities covered under FDA’s bioresearch monitoring (BIMO) program; an